| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±1.9% | +11.0% | under-priced |
| 07/23/2026 | ±3.0% | +10.4% | under-priced |
| 04/28/2026 | ±1.9% | -7.1% | under-priced |
| 02/17/2026 | ±1.9% | -9.4% | under-priced |
| 10/23/2025 | ±1.9% | -2.4% | under-priced |
| 07/24/2025 | ±2.5% | +6.0% | under-priced |
| 04/24/2025 | ±2.8% | +10.3% | under-priced |
| 02/18/2025 | ±1.6% | -5.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.59 | $1.2B | $221M |
| Q2 FY2026 | $2.15 | $1.2B | $185M |
| Q1 FY2026 | $1.59 | $1.0B | $138M |
| Q4 FY2025 | — | $1.0B | $148M |
ALLE (ALLE) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 7.8% on average — the market has tended to under-price ALLE's earnings risk. Fundamentals into the print: EPS up 18.8% year-over-year, revenue up 9.6%. QuantLogix's live 5-factor engine currently reads ALLE as a buy at 74/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →